Long Lasting High Lysine Diet Aggravates White Matter Injury in Glutaryl-CoA Dehydrogenase Deficient (Gcdh-/-) Mice.
Gcdh−/− mice
Glutaric acidemia type I
Lysine overdose
Myelin alterations
Journal
Molecular neurobiology
ISSN: 1559-1182
Titre abrégé: Mol Neurobiol
Pays: United States
ID NLM: 8900963
Informations de publication
Date de publication:
Jan 2019
Jan 2019
Historique:
received:
18
01
2018
accepted:
10
04
2018
pubmed:
21
5
2018
medline:
2
4
2019
entrez:
21
5
2018
Statut:
ppublish
Résumé
Glutaric acidemia type I (GA-I) is a neurometabolic disease caused by deficient activity of glutaryl-CoA dehydrogenase (GCDH) that results in accumulation of metabolites derived from lysine (Lys), hydroxylysine, and tryptophan catabolism. GA-I patients typically develop encephalopatic crises with striatal degeneration and progressive white matter defects. However, late onset patients as well as Gcdh-/- mice only suffer diffuse myelinopathy, suggesting that neuronal death and white matter defects are different pathophysiological events. To test this hypothesis, striatal myelin was studied in Gcdh-/- mice fed from 30 days of age during up to 60 days with a diet containing normal or moderately increased amounts of Lys (2.8%), which ensure sustained elevated levels of GA-I metabolites. Gcdh-/- mice fed with 2.8% Lys diet showed a significant decrease in striatal-myelinated areas and progressive vacuolation of white matter tracts, as compared with animals fed with normal diet. Myelin pathology increased with the time of exposure to high Lys diet and was also detected in 90-day old Gcdh-/- mice fed with normal diet, suggesting that dietary Lys accelerated the undergoing white matter damage. Gcdh-/- mice fed with 2.8% Lys diet also showed increased GRP78/BiP immunoreactivity in oligodendrocytes and neurons, denoting ER stress. However, the striatal and cortical neuronal density was unchanged with respect to normal diet. Thus, myelin damage seen in Gcdh-/- mice fed with 2.8% Lys seems to be mediated by a long-term increased levels of GA-I metabolites having deleterious effects in myelinating oligodendrocytes over neurons.
Identifiants
pubmed: 29779173
doi: 10.1007/s12035-018-1077-x
pii: 10.1007/s12035-018-1077-x
doi:
Substances chimiques
Endoplasmic Reticulum Chaperone BiP
0
Hspa5 protein, mouse
0
Glutaryl-CoA Dehydrogenase
EC 1.3.8.6
Lysine
K3Z4F929H6
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
648-657Subventions
Organisme : CNPQ
ID : (CNPq) - 470236/2012-4
Organisme : FAPERGS
ID : 10/0031-1
Organisme : PROPESQ/UFRGS
ID : PIBIT 18489
Organisme : IBN-Net
ID : # 01.06.0842-00
Organisme : INCT-EN
ID : 573677/2008-5
Organisme : PEDECIBA Biología
ID : SOlivera2017
Organisme : ANII
ID : Beca doctorado EI
Références
J Neurosci Res. 2000 Jan 1;59(1):74-85
pubmed: 10658187
J Inherit Metab Dis. 2000 Jun;23(4):359-62
pubmed: 10896294
Physiol Rev. 2001 Apr;81(2):871-927
pubmed: 11274346
Hum Mol Genet. 2002 Feb 15;11(4):347-57
pubmed: 11854167
Biochem Med. 1975 Jun;13(2):138-40
pubmed: 1191271
Neurology. 2002 Dec 10;59(11):1802-4
pubmed: 12473778
Neuropediatrics. 2002 Oct;33(5):225-31
pubmed: 12536363
Am J Med Genet C Semin Med Genet. 2003 Aug 15;121C(1):53-70
pubmed: 12888986
J Inherit Metab Dis. 2004;27(6):813-8
pubmed: 15505386
J Neurol Sci. 1992 Feb;107(2):199-204
pubmed: 1564518
Nat Cell Biol. 2005 Feb;7(2):186-94
pubmed: 15665855
Brain. 2005 Apr;128(Pt 4):711-22
pubmed: 15689364
Pediatr Res. 2005 Jun;57(6):771-6
pubmed: 15774829
J Biol Chem. 2005 Jun 10;280(23):21830-6
pubmed: 15840571
Neurology. 2005 Jun 28;64(12):2142-4
pubmed: 15985591
Brain. 2006 Apr;129(Pt 4):899-910
pubmed: 16446282
Brain. 2007 Jul;130(Pt 7):1905-20
pubmed: 17478444
J Clin Invest. 2007 Nov;117(11):3258-70
pubmed: 17932566
Proc Natl Acad Sci U S A. 2009 Mar 3;106(9):3154-9
pubmed: 19218452
Brain. 2009 Jul;132(Pt 7):1764-82
pubmed: 19433437
Acta Neuropathol. 2010 Jan;119(1):37-53
pubmed: 19847447
Biochim Biophys Acta. 2011 Mar;1808(3):761-73
pubmed: 21185260
J Biol Chem. 2011 May 20;286(20):17777-84
pubmed: 21454630
Cell Death Dis. 2012 Jun 28;3:e331
pubmed: 22739983
Mol Genet Metab. 2012 Nov;107(3):375-82
pubmed: 22999741
Mol Genet Metab. 2013 Jan;108(1):30-9
pubmed: 23218171
J Neurochem. 2013 May;125(3):334-61
pubmed: 23398367
Neurotox Res. 2014 May;25(4):381-91
pubmed: 24297153
J Neurol Sci. 2014 Sep 15;344(1-2):105-13
pubmed: 24996493
Biochim Biophys Acta. 2015 May;1852(5):768-77
pubmed: 25558815
J Inherit Metab Dis. 2015 Sep;38(5):829-38
pubmed: 25860816
Brain Res. 2015 Sep 16;1620:116-29
pubmed: 25998543
Pediatrics. 1989 Feb;83(2):228-34
pubmed: 2643800
J Neurol Sci. 2015 Dec 15;359(1-2):133-40
pubmed: 26671102
Brain Res. 2016 Oct 1;1648(Pt B):530-537
pubmed: 27021956
Exp Neurol. 2016 Sep;283(Pt B):452-75
pubmed: 27068622
Adv Exp Med Biol. 2016;949:227-243
pubmed: 27714692
Front Mol Biosci. 2017 Feb 24;4:7
pubmed: 28286750
Cell Tissue Res. 2017 Dec;370(3):391-401
pubmed: 28864831
Glia. 1996 Jun;17(2):169-74
pubmed: 8776583
Neuropediatrics. 1996 Jun;27(3):115-23
pubmed: 8837070